BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8547169)

  • 21. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Wood PJ; Nuutila M; Andersson S
    J Clin Endocrinol Metab; 2003 Jan; 88(1):493-500. PubMed ID: 12519895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in placental type 2 11beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight.
    Rogerson FM; Kayes KM; White PC
    Mol Cell Endocrinol; 1997 Apr; 128(1-2):103-9. PubMed ID: 9140081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?
    Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
    Lancet; 1993 Feb; 341(8841):355-7. PubMed ID: 8094124
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential regulation of 11 beta-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation.
    Sun K; Yang K; Challis JR
    Endocrinology; 1997 Nov; 138(11):4912-20. PubMed ID: 9348222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.
    Jansson T; Powell TL
    Clin Sci (Lond); 2007 Jul; 113(1):1-13. PubMed ID: 17536998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure.
    Benediktsson R; Calder AA; Edwards CR; Seckl JR
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):161-6. PubMed ID: 9135697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interconversion of cortisol and cortisone by 11beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta.
    Sun K; Adamson SL; Yang K; Challis JR
    Placenta; 1999 Jan; 20(1):13-9. PubMed ID: 9950140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies.
    McCalla CO; Nacharaju VL; Muneyyirci-Delale O; Glasgow S; Feldman JG
    Steroids; 1998 Oct; 63(10):511-5. PubMed ID: 9800281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal glucocorticoids and long-term programming.
    Seckl JR
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U49-62. PubMed ID: 15554887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interconversion of cortisol and cortisone in the baboon placenta at midgestation: expression of 11beta-hydroxysteroid dehydrogenase type 1 messenger RNA.
    Pepe GJ; Waddell BJ; Burch MG; Albrecht ED
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):403-10. PubMed ID: 8903424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11beta-hydroxysteroid dehydrogenase type 2 is the predominant isozyme in the guinea pig placenta: decreases in messenger ribonucleic acid and activity at term.
    Sampath-Kumar R; Matthews SG; Yang K
    Biol Reprod; 1998 Dec; 59(6):1378-84. PubMed ID: 9828181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat.
    Langley-Evans SC; Phillips GJ; Benediktsson R; Gardner DS; Edwards CR; Jackson AA; Seckl JR
    Placenta; 1996; 17(2-3):169-72. PubMed ID: 8730887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of maternal diet-induced hypertension in the rat is dependent on glucocorticoids.
    Gardner DS; Jackson AA; Langley-Evans SC
    Hypertension; 1997 Dec; 30(6):1525-30. PubMed ID: 9403577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
    Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid "programming" and PTSD risk.
    Seckl JR; Meaney MJ
    Ann N Y Acad Sci; 2006 Jul; 1071():351-78. PubMed ID: 16891583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gestation-related and betamethasone-induced changes in 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta.
    Ma XH; Wu WX; Nathanielsz PW
    Am J Obstet Gynecol; 2003 Jan; 188(1):13-21. PubMed ID: 12548190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antenatal dexamethasone: effect on ovine placental 11beta-hydroxysteroid dehydrogenase type 2 expression and fetal growth.
    Kerzner LS; Stonestreet BS; Wu KY; Sadowska G; Malee MP
    Pediatr Res; 2002 Nov; 52(5):706-12. PubMed ID: 12409517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
    Benediktsson R; Edwards CR
    Essays Biochem; 1996; 31():23-36. PubMed ID: 9078455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11-beta-hydroxysteroid dehydrogenase activity and gene expression in the hypertensive Bianchi-Milan rat.
    Stewart PM; Whorwood CB; Valentino R; Burt D; Sheppard MC; Edwards CR
    J Hypertens; 1993 Apr; 11(4):349-54. PubMed ID: 8390501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of 11 beta-hydroxysteroid dehydrogenase of human placenta: evidence for the existence of two species of 11 beta-hydroxysteroid dehydrogenase.
    Lakshmi V; Nath N; Muneyyirci-Delale O
    J Steroid Biochem Mol Biol; 1993 May; 45(5):391-7. PubMed ID: 8499346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.